Loading…
image

Report Scope & Overview:

Single-Photon Emission Computed Tomography (SPECT) Market size was valued at USD 1.76 Billion in 2022 and is projected to reach USD 3.14 Billion by 2030, growing at a CAGR of 6.7% from 2023 to 2030.

Single-Photon Emission Computed Tomography (SPECT) Market Overview:
Global Single-Photon Emission Computed Tomography (SPECT) Market research provides insights into consumer behavior, industry trends, and market competition through the use of various research techniques, including surveys, interviews, and data analysis. The industry serves a wide range of clients, including businesses, government agencies, and non-profit organizations. Single-Photon Emission Computed Tomography (SPECT) Market is highly diverse, with a range of services and specialties, including quantitative and qualitative research, brand research, product testing, customer satisfaction research, and competitive analysis.

DESCIMG1

Single-Photon Emission Computed Tomography (SPECT) Market Key Trends

Technological advancements: There have been significant advancements in SPECT imaging technology, leading to improved image quality, faster scan times, and enhanced diagnostic capabilities. These advancements include the development of hybrid imaging systems combining SPECT with other modalities like computed tomography (CT) or magnetic resonance imaging (MRI).

Growing applications in various medical fields: SPECT imaging is widely used in several medical specialties, including cardiology, neurology, oncology, and psychiatry. The expanding applications of SPECT in diagnosing and monitoring various diseases are driving market growth.

Rising prevalence of chronic diseases: The increasing incidence of chronic diseases, such as cardiovascular disorders, cancer, and neurological disorders, is driving the demand for SPECT imaging for accurate diagnosis, disease staging, and treatment planning.

Increasing adoption of molecular imaging techniques: Molecular imaging techniques, including SPECT, are gaining popularity due to their ability to provide functional and metabolic information about tissues and organs. This non-invasive approach is particularly valuable in personalized medicine and targeted therapy.

Growing geriatric population: The aging population is more prone to age-related diseases, including cardiovascular conditions and neurodegenerative disorders, where SPECT imaging plays a crucial role in diagnosis and management. The expanding geriatric population is, therefore, contributing to the growth of the SPECT market.

Focus on radiation dose reduction: With increasing concerns about radiation exposure, efforts are being made to optimize SPECT imaging protocols and reduce radiation dose without compromising image quality. Manufacturers are developing technologies and software solutions to enhance image acquisition and reconstruction, leading to lower radiation exposure for patients.

Integration of artificial intelligence (AI): The integration of AI and machine learning algorithms in SPECT imaging is gaining traction. AI-based solutions can aid in image interpretation, improving diagnostic accuracy and efficiency. These technologies have the potential to enhance image quality, reduce image artifacts, and automate analysis processes.

Reimbursement and regulatory challenges: The SPECT market faces challenges related to reimbursement policies and regulatory requirements. The evolving healthcare reimbursement landscape and the need for regulatory compliance impact the adoption and utilization of SPECT systems.

 Market Segmentations:

Global Single-Photon Emission Computed Tomography (SPECT) Market: By Company
• GE Healthcare
• Siemens Healthcare
• Koninklijke Philips N.V.
• Bruker Corporation
• Mediso Ltd.
• Toshiba Medical (Canon)
• Digirad Corporation
• Spectrum Dynamics Medical
• DDD-Diagnostic A/S
• MiE America, Inc.
• CardiArc
• Beijing Hamamatsu Photon Techniques INC.
• SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
• PNPMed
• NuCare Inc.

Global Single-Photon Emission Computed Tomography (SPECT) Market: By Type
• Single Imaging Gamma Cameras
• SPECT/CT

Global Single-Photon Emission Computed Tomography (SPECT) Market: By Application
• Hospitals
• Diagnostic Imaging Centres
• Ambulatory Surgical Centres

Global Single-Photon Emission Computed Tomography (SPECT) Market: Regional Analysis
All the regional segmentation has been studied based on recent and future trends, and the market is forecasted throughout the prediction period. The countries covered in the regional analysis of the Global Single-Photon Emission Computed Tomography (SPECT) market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium, and Rest of Europe in Europe, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, China, Japan, India, South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), and Argentina, Brazil, and Rest of South America as part of South America.

Report Attribute/MetricDetails
Market Size 2022USD 1.76 Billion
Market Size 2030USD 3.14 Billion
Compound Annual Growth Rate (CAGR)6.7%(2023-2030)
Base Year2022
Forecast Period2023-2032
Historical Data2018-2022
Forecast UnitsValue (USD Billion)
Report CoverageRevenue Forecast, Competitive Landscape,
Growth Factors, and Trends 
By Type• Single Imaging Gamma Cameras
• SPECT/CT
By Application• Hospitals
• Diagnostic Imaging Centres
• Ambulatory Surgical Centres
Key Companies Profiled• GE Healthcare
• Siemens Healthcare
• Koninklijke Philips N.V.
• Bruker Corporation
• Mediso Ltd.
• Toshiba Medical (Canon)
• Digirad Corporation
• Spectrum Dynamics Medical
• DDD-Diagnostic A/S
• MiE America, Inc.
• CardiArc
• Beijing Hamamatsu Photon Techniques INC.
• SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
• PNPMed
• NuCare Inc.
Regions and Key Countries CoveredU.S., Canada, and Mexico in North America, Germany, France, U.K.,
Russia, Italy, Spain, Turkey, Netherlands, Switzerland, Belgium,
and Rest of Europe in Europe, Singapore, Malaysia, Australia,
Thailand, Indonesia, Philippines, China, Japan, India,
South Korea, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC),
Saudi Arabia, U.A.E, South Africa, Egypt, Israel,
Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA),
and Argentina, Brazil, and Rest of South America as part of South America
Customization ScopeAvailable on Request


Reasons to Purchase Single-Photon Emission Computed Tomography (SPECT) Market Report:
• To gain insights into market trends and dynamics: this reports provide valuable insights into industry trends and dynamics, including market size, growth rates, and key drivers and challenges.
• To identify key players and competitors: this research reports can help businesses identify key players and competitors in their industry, including their market share, strategies, and strengths and weaknesses.
• To understand consumer behavior: this research reports can provide valuable insights into consumer behavior, including their preferences, purchasing habits, and demographics.
• To evaluate market opportunities: this research reports can help businesses evaluate market opportunities, including potential new products or services, new markets, and emerging trends.
• To make informed business decisions: this research reports provide businesses with data-driven insights that can help them make informed business decisions, including strategic planning, product development, and marketing and advertising strategies.

Objectives of Single-Photon Emission Computed Tomography (SPECT) Market Study:
The objectives of Single-Photon Emission Computed Tomography (SPECT) market research report may vary depending on the specific needs and goals of the business or organization commissioning the report. However, some common objectives of market research reports include:
• Understanding the market size and potential: One of the primary objectives of Single-Photon Emission Computed Tomography (SPECT) market research is to understand the size and potential of a particular market. This includes analyzing market trends and dynamics, identifying key players and competitors, and assessing the demand for products or services.
• Identifying target customers and segments: this market research reports can help businesses identify and understand their target customers and market segments, including their preferences, behaviors, and demographics. This information can be used to develop targeted marketing and advertising strategies.
• Evaluating product or service performance: this market research reports can provide valuable insights into the performance of products or services, including customer satisfaction, product usage, and product quality. This information can be used to improve products or services and enhance customer satisfaction.
• Assessing market opportunities and threats: this market research reports can help businesses identify potential market opportunities and threats, including emerging trends, competitive threats, and new market entrants. This information can be used to develop strategic plans and make informed business decisions.
• Developing effective marketing and advertising strategies: this market research reports can help businesses develop effective marketing and advertising strategies by providing insights into customer preferences and behavior, competitive dynamics, and market trends. This can help businesses improve brand awareness, customer engagement, and overall marketing effectiveness.

Frequently Asked Questions

  Single-Photon Emission Computed Tomography (SPECT) Market size was valued at USD 1.76 Billion in 2022 and is projected to reach USD 3.14 Billion by 2030, growing at a CAGR of 6.7% from 2023 to 2030.

  The major factors driving the growth of the SPECT market include technological advancements in imaging technology, increasing applications in various medical fields, the rising prevalence of chronic diseases, the growing geriatric population, and the integration of artificial intelligence in SPECT imaging.

  North America currently holds the largest market share in the SPECT market, followed by Europe. However, the market is also growing in the Asia Pacific region.

  The key players in the SPECT market include major healthcare technology companies such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Toshiba Medical Systems Corporation, among others.

  The major challenges faced by the SPECT market include reimbursement and regulatory challenges, concerns about radiation dose exposure, and competition from alternative imaging modalities.

TABLE OF CONTENT

1 Single-Photon Emission Computed Tomography (SPECT) Market Overview
1.1 Product Overview and Scope of Single-Photon Emission Computed Tomography (SPECT)
1.2 Single-Photon Emission Computed Tomography (SPECT) Segment by Type
1.2.1 Global Single-Photon Emission Computed Tomography (SPECT) Market Value Comparison by Type (2023-2029)
1.2.2 Single Imaging Gamma Cameras
1.2.3 SPECT/CT
1.3 Single-Photon Emission Computed Tomography (SPECT) Segment by Application
1.3.1 Global Single-Photon Emission Computed Tomography (SPECT) Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Diagnostic Imaging Centres
1.3.4 Ambulatory Surgical Centres
1.4 Global Single-Photon Emission Computed Tomography (SPECT) Market Size Estimates and Forecasts
1.4.1 Global Single-Photon Emission Computed Tomography (SPECT) Revenue 2017-2032
1.4.2 Global Single-Photon Emission Computed Tomography (SPECT) Sales 2017-2032
1.4.3 Global Single-Photon Emission Computed Tomography (SPECT) Market Average Price (2017-2032)
1.5 Assumptions and Limitations
2 Single-Photon Emission Computed Tomography (SPECT) Market Competition by Manufacturers
2.1 Global Single-Photon Emission Computed Tomography (SPECT) Sales Market Share by Manufacturers (2017-2023)
2.2 Global Single-Photon Emission Computed Tomography (SPECT) Revenue Market Share by Manufacturers (2017-2023)
2.3 Global Single-Photon Emission Computed Tomography (SPECT) Average Price by Manufacturers (2017-2023)
2.4 Global Single-Photon Emission Computed Tomography (SPECT) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Single-Photon Emission Computed Tomography (SPECT), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Single-Photon Emission Computed Tomography (SPECT), Product Type & Application
2.7 Single-Photon Emission Computed Tomography (SPECT) Market Competitive Situation and Trends
2.7.1 Single-Photon Emission Computed Tomography (SPECT) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Single-Photon Emission Computed Tomography (SPECT) Players Market Share by Revenue
2.7.3 Global Single-Photon Emission Computed Tomography (SPECT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Single-Photon Emission Computed Tomography (SPECT) Retrospective Market Scenario by Region
3.1 Global Single-Photon Emission Computed Tomography (SPECT) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Single-Photon Emission Computed Tomography (SPECT) Global Single-Photon Emission Computed Tomography (SPECT) Sales by Region: 2017-2032
3.2.1 Global Single-Photon Emission Computed Tomography (SPECT) Sales by Region: 2017-2023
3.2.2 Global Single-Photon Emission Computed Tomography (SPECT) Sales by Region: 2023-2032
3.3 Global Single-Photon Emission Computed Tomography (SPECT) Global Single-Photon Emission Computed Tomography (SPECT) Revenue by Region: 2017-2032
3.3.1 Global Single-Photon Emission Computed Tomography (SPECT) Revenue by Region: 2017-2023
3.3.2 Global Single-Photon Emission Computed Tomography (SPECT) Revenue by Region: 2023-2032
3.4 North America Single-Photon Emission Computed Tomography (SPECT) Market Facts & Figures by Country
3.4.1 North America Single-Photon Emission Computed Tomography (SPECT) Market Size by Country: 2018 VS 2023 VS 2032
3.4.2 North America Single-Photon Emission Computed Tomography (SPECT) Sales by Country (2017-2032)
3.4.3 North America Single-Photon Emission Computed Tomography (SPECT) Revenue by Country (2017-2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Single-Photon Emission Computed Tomography (SPECT) Market Facts & Figures by Country
3.5.1 Europe Single-Photon Emission Computed Tomography (SPECT) Market Size by Country: 2018 VS 2023 VS 2032
3.5.2 Europe Single-Photon Emission Computed Tomography (SPECT) Sales by Country (2017-2032)
3.5.3 Europe Single-Photon Emission Computed Tomography (SPECT) Revenue by Country (2017-2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Single-Photon Emission Computed Tomography (SPECT) Market Facts & Figures by Country
3.6.1 Asia Pacific Single-Photon Emission Computed Tomography (SPECT) Market Size by Country: 2018 VS 2023 VS 2032
3.6.2 Asia Pacific Single-Photon Emission Computed Tomography (SPECT) Sales by Country (2017-2032)
3.6.3 Asia Pacific Single-Photon Emission Computed Tomography (SPECT) Revenue by Country (2017-2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Single-Photon Emission Computed Tomography (SPECT) Market Facts & Figures by Country
3.7.1 Latin America Single-Photon Emission Computed Tomography (SPECT) Market Size by Country: 2018 VS 2023 VS 2032
3.7.2 Latin America Single-Photon Emission Computed Tomography (SPECT) Sales by Country (2017-2032)
3.7.3 Latin America Single-Photon Emission Computed Tomography (SPECT) Revenue by Country (2017-2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Single-Photon Emission Computed Tomography (SPECT) Market Facts & Figures by Country
3.8.1 Middle East and Africa Single-Photon Emission Computed Tomography (SPECT) Market Size by Country: 2018 VS 2023 VS 2032
3.8.2 Middle East and Africa Single-Photon Emission Computed Tomography (SPECT) Sales by Country (2017-2032)
3.8.3 Middle East and Africa Single-Photon Emission Computed Tomography (SPECT) Revenue by Country (2017-2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Single-Photon Emission Computed Tomography (SPECT) Sales by Type (2017-2032)
4.1.1 Global Single-Photon Emission Computed Tomography (SPECT) Sales by Type (2017-2023)
4.1.2 Global Single-Photon Emission Computed Tomography (SPECT) Sales by Type (2023-2032)
4.1.3 Global Single-Photon Emission Computed Tomography (SPECT) Sales Market Share by Type (2017-2032)
4.2 Global Single-Photon Emission Computed Tomography (SPECT) Revenue by Type (2017-2032)
4.2.1 Global Single-Photon Emission Computed Tomography (SPECT) Revenue by Type (2017-2023)
4.2.2 Global Single-Photon Emission Computed Tomography (SPECT) Revenue by Type (2023-2032)
4.2.3 Global Single-Photon Emission Computed Tomography (SPECT) Revenue Market Share by Type (2017-2032)
4.3 Global Single-Photon Emission Computed Tomography (SPECT) Price by Type (2017-2032)
5 Segment by Application
5.1 Global Single-Photon Emission Computed Tomography (SPECT) Sales by Application (2017-2032)
5.1.1 Global Single-Photon Emission Computed Tomography (SPECT) Sales by Application (2017-2023)
5.1.2 Global Single-Photon Emission Computed Tomography (SPECT) Sales by Application (2023-2032)
5.1.3 Global Single-Photon Emission Computed Tomography (SPECT) Sales Market Share by Application (2017-2032)
5.2 Global Single-Photon Emission Computed Tomography (SPECT) Revenue by Application (2017-2032)
5.2.1 Global Single-Photon Emission Computed Tomography (SPECT) Revenue by Application (2017-2023)
5.2.2 Global Single-Photon Emission Computed Tomography (SPECT) Revenue by Application (2023-2032)
5.2.3 Global Single-Photon Emission Computed Tomography (SPECT) Revenue Market Share by Application (2017-2032)
5.3 Global Single-Photon Emission Computed Tomography (SPECT) Price by Application (2017-2032)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue and Gross Margin (2017-2023)
6.1.4 GE Healthcare Single-Photon Emission Computed Tomography (SPECT) Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Siemens Healthcare
6.2.1 Siemens Healthcare Corporation Information
6.2.2 Siemens Healthcare Description and Business Overview
6.2.3 Siemens Healthcare Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue and Gross Margin (2017-2023)
6.2.4 Siemens Healthcare Single-Photon Emission Computed Tomography (SPECT) Product Portfolio
6.2.5 Siemens Healthcare Recent Developments/Updates
6.3 Koninklijke Philips N.V.
6.3.1 Koninklijke Philips N.V. Corporation Information
6.3.2 Koninklijke Philips N.V. Description and Business Overview
6.3.3 Koninklijke Philips N.V. Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue and Gross Margin (2017-2023)
6.3.4 Koninklijke Philips N.V. Single-Photon Emission Computed Tomography (SPECT) Product Portfolio
6.3.5 Koninklijke Philips N.V. Recent Developments/Updates
6.4 Bruker Corporation
6.4.1 Bruker Corporation Corporation Information
6.4.2 Bruker Corporation Description and Business Overview
6.4.3 Bruker Corporation Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Bruker Corporation Single-Photon Emission Computed Tomography (SPECT) Product Portfolio
6.4.5 Bruker Corporation Recent Developments/Updates
6.5 Mediso Ltd.
6.5.1 Mediso Ltd. Corporation Information
6.5.2 Mediso Ltd. Description and Business Overview
6.5.3 Mediso Ltd. Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue and Gross Margin (2017-2023)
6.5.4 Mediso Ltd. Single-Photon Emission Computed Tomography (SPECT) Product Portfolio
6.5.5 Mediso Ltd. Recent Developments/Updates
6.6 Toshiba Medical (Canon)
6.6.1 Toshiba Medical (Canon) Corporation Information
6.6.2 Toshiba Medical (Canon) Description and Business Overview
6.6.3 Toshiba Medical (Canon) Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue and Gross Margin (2017-2023)
6.6.4 Toshiba Medical (Canon) Single-Photon Emission Computed Tomography (SPECT) Product Portfolio
6.6.5 Toshiba Medical (Canon) Recent Developments/Updates
6.7 Digirad Corporation
6.6.1 Digirad Corporation Corporation Information
6.6.2 Digirad Corporation Description and Business Overview
6.6.3 Digirad Corporation Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Digirad Corporation Single-Photon Emission Computed Tomography (SPECT) Product Portfolio
6.7.5 Digirad Corporation Recent Developments/Updates
6.8 Spectrum Dynamics Medical
6.8.1 Spectrum Dynamics Medical Corporation Information
6.8.2 Spectrum Dynamics Medical Description and Business Overview
6.8.3 Spectrum Dynamics Medical Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Spectrum Dynamics Medical Single-Photon Emission Computed Tomography (SPECT) Product Portfolio
6.8.5 Spectrum Dynamics Medical Recent Developments/Updates
6.9 DDD-Diagnostic A/S
6.9.1 DDD-Diagnostic A/S Corporation Information
6.9.2 DDD-Diagnostic A/S Description and Business Overview
6.9.3 DDD-Diagnostic A/S Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue and Gross Margin (2017-2023)
6.9.4 DDD-Diagnostic A/S Single-Photon Emission Computed Tomography (SPECT) Product Portfolio
6.9.5 DDD-Diagnostic A/S Recent Developments/Updates
6.10 MiE America, Inc.
6.10.1 MiE America, Inc. Corporation Information
6.10.2 MiE America, Inc. Description and Business Overview
6.10.3 MiE America, Inc. Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue and Gross Margin (2017-2023)
6.10.4 MiE America, Inc. Single-Photon Emission Computed Tomography (SPECT) Product Portfolio
6.10.5 MiE America, Inc. Recent Developments/Updates
6.11 CardiArc
6.11.1 CardiArc Corporation Information
6.11.2 CardiArc Single-Photon Emission Computed Tomography (SPECT) Description and Business Overview
6.11.3 CardiArc Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue and Gross Margin (2017-2023)
6.11.4 CardiArc Single-Photon Emission Computed Tomography (SPECT) Product Portfolio
6.11.5 CardiArc Recent Developments/Updates
6.12 Beijing Hamamatsu Photon Techniques INC.
6.12.1 Beijing Hamamatsu Photon Techniques INC. Corporation Information
6.12.2 Beijing Hamamatsu Photon Techniques INC. Single-Photon Emission Computed Tomography (SPECT) Description and Business Overview
6.12.3 Beijing Hamamatsu Photon Techniques INC. Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue and Gross Margin (2017-2023)
6.12.4 Beijing Hamamatsu Photon Techniques INC. Single-Photon Emission Computed Tomography (SPECT) Product Portfolio
6.12.5 Beijing Hamamatsu Photon Techniques INC. Recent Developments/Updates
6.13 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
6.13.1 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD. Corporation Information
6.13.2 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD. Single-Photon Emission Computed Tomography (SPECT) Description and Business Overview
6.13.3 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD. Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue and Gross Margin (2017-2023)
6.13.4 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD. Single-Photon Emission Computed Tomography (SPECT) Product Portfolio
6.13.5 SHENZHEN BASDA MEDICAL APPARATUS CO., LTD. Recent Developments/Updates
6.14 PNPMed
6.14.1 PNPMed Corporation Information
6.14.2 PNPMed Single-Photon Emission Computed Tomography (SPECT) Description and Business Overview
6.14.3 PNPMed Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue and Gross Margin (2017-2023)
6.14.4 PNPMed Single-Photon Emission Computed Tomography (SPECT) Product Portfolio
6.14.5 PNPMed Recent Developments/Updates
6.15 NuCare Inc.
6.15.1 NuCare Inc. Corporation Information
6.15.2 NuCare Inc. Single-Photon Emission Computed Tomography (SPECT) Description and Business Overview
6.15.3 NuCare Inc. Single-Photon Emission Computed Tomography (SPECT) Sales, Revenue and Gross Margin (2017-2023)
6.15.4 NuCare Inc. Single-Photon Emission Computed Tomography (SPECT) Product Portfolio
6.15.5 NuCare Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Single-Photon Emission Computed Tomography (SPECT) Industry Chain Analysis
7.2 Single-Photon Emission Computed Tomography (SPECT) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Single-Photon Emission Computed Tomography (SPECT) Production Mode & Process
7.4 Single-Photon Emission Computed Tomography (SPECT) Sales and Marketing
7.4.1 Single-Photon Emission Computed Tomography (SPECT) Sales Channels
7.4.2 Single-Photon Emission Computed Tomography (SPECT) Distributors
7.5 Single-Photon Emission Computed Tomography (SPECT) Customers
8 Single-Photon Emission Computed Tomography (SPECT) Market Dynamics
8.1 Single-Photon Emission Computed Tomography (SPECT) Industry Trends
8.2 Single-Photon Emission Computed Tomography (SPECT) Market Drivers
8.3 Single-Photon Emission Computed Tomography (SPECT) Market Challenges
8.4 Single-Photon Emission Computed Tomography (SPECT) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

GE Healthcare
Siemens Healthcare
Koninklijke Philips N.V.
Bruker Corporation
Mediso Ltd.
Toshiba Medical (Canon)
Digirad Corporation
Spectrum Dynamics Medical
DDD-Diagnostic A/S
MiE America, Inc.
CardiArc
Beijing Hamamatsu Photon Techniques INC.
SHENZHEN BASDA MEDICAL APPARATUS CO., LTD.
PNPMed
NuCare Inc.

Request Sample